We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Siemens Healthineers - Laboratory Diagnostics

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App




Ready-To-Use Panels Fulfill CLIA’s Performance Specifications for Assay Verification

By LabMedica International staff writers
Posted on 12 Sep 2023
Print article
Image: AccuSet HIV Verification Panel is a 20-member validation panel of undiluted, naturally occurring plasma samples (Photo courtesy of LGC)
Image: AccuSet HIV Verification Panel is a 20-member validation panel of undiluted, naturally occurring plasma samples (Photo courtesy of LGC)

LGC Clinical Diagnostics (Middlesex, UK) - SeraCare (Milford, MA, USA) has launched its AccuSet HIV Verification Panels - ready-to-use panels designed to fulfill ISO and CLIA’s Performance Specifications for assay verification.

The AccuSet HIV Verification Panels are a great tool to help install a new HIV test method and perform assay verification, as well as help evaluate assay performance during development, performing assay validation, and troubleshoot test methods. These panels consist of naturally occurring plasma samples that perfectly mimic patient specimens on laboratory instrumentation. The panels include highly characterized mixed-titer samples that will allow users to efficiently onboard their new assays.

The company offers two HIV Verification Panels to provide labs with options for onboarding both molecular and serological HIV assays based on their specific verification requirements. With the choice of one or both verification panels, labs can tailor their selection to match specific verification protocols. The AccuSet HIV Verification Panels provide the tools labs need to easily meet CLIA’s performance specifications so that users can verify their test system and start reporting patient results.

Related Links:
LGC 
SeraCare 

New
Platinum Supplier
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
New
Gold Supplier
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
New
Lipoprotein (a) Assay
Lipoprotein (a) Assay
New
Measles Virus Antibody Test
Chorus MEASLES IgG

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Hematology

view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more

Immunology

view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more

Microbiology

view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more

Pathology

view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more

Industry

view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.